Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1% Clascoterone Cream for Moderate-to-Severe Facial Acne Vulgaris
CTR20241222Phase 3Active
- Sponsor
- Sun Pharma
- Start
- May 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clascoterone in acne vulgaris, sponsored by Sun Pharma. Started May 2024; status: active.
02
Drugs
clascoterone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on CTR20241222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241222.